FDA.reportPublic FDA data

casimersen 50 MG/ML per 2 ML Injection

RxCUI
2480100
RxNorm name
casimersen 50 MG/ML per 2 ML Injection
Display name
casimersen 50 MG/ML per 2 ML Injection
Full name
casimersen 50 MG/ML per 2 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AMONDYS 45CASIMERSENSarepta Therapeutics, Inc.e9e5fd44-eeda-4580-bba1-a734828bbcc32026-01-09Warnings, Adverse reactionsExact identifier
rxcui: 2480100

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e9e5fd44-eeda-4580-bba1-a734828bbcc3casimersen 100 MG in 2 ML Injection [PSN] · 2 ML casimersen 50 MG/ML Injection [SCD] · casimersen 100 MG per 2 ML Injection [SY] · casimersen 50 MG/ML per 2 ML Injection [SY]411These highlights do not include all the information needed to use AMONDYS 45 ® safely and effectively. See full prescribing information for AMONDYS 45. AMONDYS 45 (casimersen) injection, for intravenous use Initial U.S. Approval: 202120260109